Human Oncology & Pathogenesis Program

The Omar Abdel-Wahab Lab

Research

Pictured: Dr. Abdel-Wahab
Omar Abdel-Wahab, MD
Associate Member, Human Oncology and Pathogenesis Program; Associate Attending, Leukemia Service; Director, MSK Center for Hematologic Malignancies

Omar Abdel-Wahab is an Associate Member in Human Oncology and Pathogenesis Program (HOPP) and an Associate Attending Physician on the Leukemia Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center. Dr. Abdel-Wahab’s research focuses on the role of genomic alterations in the pathogenesis of hematopoietic malignancies.

View Lab Overview

The Omar Abdel-Wahab Lab

Publications

View All Publications

People

Pictured: Dr. Abdel-Wahab

Omar Abdel-Wahab, MD

Associate Member, Human Oncology and Pathogenesis Program; Associate Attending, Leukemia Service; Director, MSK Center for Hematologic Malignancies

  • Physician-scientist Omar Abdel-Wahab studies the functional genomics of hematopoietic malignancies.
  • MD, Duke University School of Medicine
abdelwao@mskcc.org
Email Address
View physician profile
Physician profile

Members

Sisi Chen
Sisi Chen
Ha Na Cho, Research Assistant
Hana Cho

Research Assistant

Daniel Cui
Daniel Cui

Research Technician

Benjamin Durham, Instructor (Pathology)
Benjamin Durham

Instructor (Pathology)

Caroline Erickson
Caroline Erickson
Simon Hogg
Simon Hogg
Bo Liu, Research Associate
Bo Liu

Research Associate

Sydney Lu, Research Fellow
Sydney Lu

Assistant Member, Myeloma Service

Alexander Penson, PhD
Alexander Penson

Senior Computational Biologist

Danielle Richards
Danielle Richards

Administrative Assistant

Akihide Yoshimi, Senior Research Scientist
Akihide Yoshimi

Senior Research Scientist

Lab Alumni
Jihae Ahn
Jihae Ahn

Volunteer

Shlomzion Aumann
Shlomzion Aumann

Research Fellow

Lillian Bitner, Research Technician
Lillian Bitner

Research Technician

Young Rock Chung
Young Rock Chung

Research Technician

Luisa Escobar Hoyos

Research Fellow

Monisha Hosier
Monisha Hosier

Administrative Assistant II

Daichi Inoue, Visiting Investigator
Daichi Inoue

Visiting Investigator

Michelle Ki
Michelle Ki

Research Technician

Eunhee Kim
Eunhee Kim

Research Fellow

Min Kim
Min Kim

Research Technician

Pictured: Stanley Lee
Stanley Lee

Research Associate

Jean Baptiste Micol
Jean Baptiste Micol

Research Fellow

Alessandro Pastore, Senior Research Scientist
Alessandro Pastore

Senior Research Scientist

Ruth Saganty
Ruth Saganty
Justin Taylor

Instructor (Dept. of Medicine)

Xiao Zhang
Lab Affilations

Achievements

  • Seldin-Smith Award for Pioneering Research, American Society of Clinical Investigation
  • Pershing Square Sohn Prize for Young Investigators in Cancer Research
  • Leukemia & Lymphoma Society Clinical Scholar Award
  • Joanne Levy Memorial Award for Outstanding Achievement, American Society of Hematology
  • V Scholar Award, V Foundation
Read more
  • Junior Faculty Scholar Award, American Society of Hematology (ASH)
  • Damon Runyon Clinical Investigator Award

Get in Touch

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Omar Abdel-Wahab discloses the following relationships and financial interests:

  • AIchemy, Inc.
    Ownership / Equity Interests; Provision of Services (uncompensated)
  • Envisagenics
    Ownership / Equity Interests; Provision of Services (uncompensated)
  • Epizyme
    Intellectual Property Rights
  • Janssen Global Services, LLC
    Provision of Services

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures